ELASTRIN

Leveraging a platform technology to develop therapeutics targeting damaged elastin fiber, rendering calcified tissue and organs supple again... 1 of every 3 adults suffers from cardiovascular disease, but only about half of the people have their condition under control. They are the leading cause of death globally with an estimated 17.9 million people died in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke... Elastrin Therapeutics platform technology a solution to heart disease, stroke, high blood pressure, copd and aneurysm. These diseases can be cured by our treatment; a nanoparticle that specifically targets elastin and is able to reverse calcification in the arteries and other tissues.

Primary location: Simpsonville United States